Use access key #2 to skip to page content.
$57.78 -1.48 (-2.50%)
1/9/2009 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

1

Avatar xmilkman207 (< 20) Submitted: 2/16/08 10:49 AM : Outperform Start Price: $47.17 AMGN Score: 57.41

this biotech is ready to get it together.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links